symbol,statement_type,period_end,line_item,value
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.242223
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Normalized EBITDA,11526000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Total Unusual Items,
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,5578000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,3796000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,313107000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,EBITDA,11526000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,EBIT,7730000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Net Interest Income,-369000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Interest Expense,369000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Interest Income,
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Normalized Income,5578000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,5578000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Total Expenses,329343000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Basic Average Shares,
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Diluted EPS,
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Basic EPS,
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,5578000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,5578000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Net Income,5578000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,5578000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Net Income Extraordinary,0.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Net Income Discontinuous Operations,0.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,5578000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Tax Provision,1783000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Pretax Income,7361000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,3052000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Special Income Charges,
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Other Special Charges,
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-369000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,369000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Operating Income,4679000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Operating Expense,16236000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Other Operating Expenses,
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,3796000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,3796000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Selling General And Administration,4590000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,435000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,General And Administrative Expense,4155000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Gross Profit,20915000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Cost Of Revenue,313107000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Total Revenue,334022000.0
BIOFILCHEM.NS,income,2025-03-31 00:00:00,Operating Revenue,334022000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.1804
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Normalized EBITDA,13062000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Total Unusual Items,0.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,7092000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,3994000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,381209000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,EBITDA,13062000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,EBIT,9068000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Net Interest Income,-415000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Interest Expense,415000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Interest Income,67000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Normalized Income,7092000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,7092000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Total Expenses,396181000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Diluted Average Shares,16118182.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Basic Average Shares,16118182.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Diluted EPS,0.44
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Basic EPS,0.44
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,7092000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,7092000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Net Income,7092000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,7092000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Net Income Extraordinary,0.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Net Income Discontinuous Operations,0.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,7092000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Tax Provision,1561000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Pretax Income,8653000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,4897000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Special Income Charges,0.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Other Special Charges,
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-415000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,20000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,415000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,67000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Operating Income,4172000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Operating Expense,14972000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Other Operating Expenses,8885000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,3994000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,3994000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Selling General And Administration,4274000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,431000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,General And Administrative Expense,3843000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Gross Profit,19144000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Cost Of Revenue,381209000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Total Revenue,400353000.0
BIOFILCHEM.NS,income,2024-03-31 00:00:00,Operating Revenue,400353000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.2342
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Normalized EBITDA,12640000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Total Unusual Items,0.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,5604000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,4291000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,274233000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,EBITDA,12640000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,EBIT,8349000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Net Interest Income,-409000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Interest Expense,419000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Interest Income,16000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Normalized Income,5604000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,5604000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Total Expenses,292966000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Diluted Average Shares,16273800.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Basic Average Shares,16273800.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Diluted EPS,0.34
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Basic EPS,0.34
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,5604000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,5604000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Net Income,5604000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,5604000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Net Income Extraordinary,0.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Net Income Discontinuous Operations,0.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,5604000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Tax Provision,2326000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Pretax Income,7930000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,954000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Special Income Charges,0.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Other Special Charges,
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-409000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,6000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,419000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,16000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Operating Income,7386000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Operating Expense,18733000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Other Operating Expenses,6663000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,4291000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,4291000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Selling General And Administration,1525000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,162000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,General And Administrative Expense,1363000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Gross Profit,26119000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Cost Of Revenue,274233000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Total Revenue,300352000.0
BIOFILCHEM.NS,income,2023-03-31 00:00:00,Operating Revenue,300352000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.3433
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Normalized EBITDA,14915000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Total Unusual Items,0.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,6984000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,4376000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,194604000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,EBITDA,14915000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,EBIT,10539000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Net Interest Income,-196000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Interest Expense,390000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Interest Income,210000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Normalized Income,6984000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,6984000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Total Expenses,214773000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Diluted Average Shares,16273800.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Basic Average Shares,16273800.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Diluted EPS,0.44
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Basic EPS,0.44
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,6984000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,6984000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Net Income,6984000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,6984000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Net Income Extraordinary,
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Net Income Discontinuous Operations,0.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,6984000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Tax Provision,3165000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Pretax Income,10149000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,1293000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Special Income Charges,0.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Other Special Charges,
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-196000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,16000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,390000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,210000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Operating Income,9050000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Operating Expense,20169000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Other Operating Expenses,5784000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,4275000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,4275000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Selling General And Administration,1953000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,74000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,General And Administrative Expense,1879000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Gross Profit,29219000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Cost Of Revenue,194604000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Total Revenue,223823000.0
BIOFILCHEM.NS,income,2022-03-31 00:00:00,Operating Revenue,223823000.0
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Total Unusual Items,2753000.0
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,2753000.0
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,EBITDA,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,EBIT,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Net Interest Income,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Interest Expense,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Interest Income,214000.0
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Normalized Income,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Total Expenses,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Diluted Average Shares,16273800.0
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Basic Average Shares,16273800.0
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Diluted EPS,0.77
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Basic EPS,0.77
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Net Income,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Net Income Extraordinary,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Net Income Discontinuous Operations,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Tax Provision,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Pretax Income,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Special Income Charges,2753000.0
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Other Special Charges,-2753000.0
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,39000.0
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,214000.0
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Operating Income,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Operating Expense,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Other Operating Expenses,6268000.0
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Selling General And Administration,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,General And Administrative Expense,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Gross Profit,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Total Revenue,
BIOFILCHEM.NS,income,2021-03-31 00:00:00,Operating Revenue,
